21216 ⎘
Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen; Proteins Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
METHODS FOR PRODUCTION OF CAPSULAR POLYSACCHARIDE PROTEIN CONJUGATES FROM STREPTOCOCCUS PNEUMONIAE SEROTYPE 19F
#2HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
#3VACCINE AGAINST KLEBSIELLA PNEUMONIAE
#4VACCINATION AGAINST PNEUMOCCOCAL AND COVID-19 INFECTIONS
#5LIPIDATED TLR7/8 MODULATORS AS ADJUVANTS AND USES THEREOF
#6TREATMENT AND/OR PREVENTION OF AN INFECTION BY MONO/DIVALENT AND POLYVALENT ANTIGEN PARTICLE-MEDIATED IMMUNE RESPONSES
#7Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens
#8OPTIMIZED EPICUTANEOUS VACCINATION
#9IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#10SUPERANTIGEN VACCINE CONJUGATE FOR THE TREATMENT OF CANCER
#11METHOD FOR THE PURIFICATION OF CAPSULAR POLYSACCHARIDES
#12Vaccines and Antibodies for the Treatment and Prevention of Neurodegenerative Disorders and Inflammation Related Health Conditions
#13Methods for the Rapid Manufacture of Conjugate Vaccines that Elicit Robust Immune Responses
#14HPV Virus-Like Particle Bioconjugates
#15IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#16IMMUNOGENIC PROTECTIVE ANTIGEN CONJUGATES
#17ADJUVANTED IMMUNOGENIC COMPOSITION AGAINST NEISSERIA MENINGITIDIS B
#18IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#19IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES
#20Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#21INTRANASAL POLYSACCHARIDE CONJUGATE NANOMULSION VACCINES AND METHODS OF USING THE SAME
#22Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
#23VACCINE
#24POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE CONJUGATE VACCINE COMPONENT AND APPLICATION THEREOF
#25COMPOSITIONS, METHODS AND USES FOR ELICITING AN IMMUNE RESPONSE
#26PEPTIDE VACCINES AGAINST INTERLEUKIN-31
#27VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE
#28COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER
#29Process for Producing of Vaccine Formulations With Preservatives
#30mRNA VACCINES COMPRISING IL-4 AND/OR IL-13 RNA AND USES THEREOF
#31THERAPEUTIC RNA FOR LUNG CANCER
#32Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
#33VACCINATION AGAINST BACTERIAL AND BETACORONAVIRUS INFECTIONS
#34IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED ESCHERICHIA COLI SACCHARIDES AND USES THEREOF
#35VACCINE COMPOSITION FOR BREAKING SELF-TOLERANCE
#36NOVEL NUCLEIC ACID MOLECULE
#37SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF
#38Protein-Saccharide Conjugation with Sodium Cyanoborohydride
#39ALPHAVIRUS ANTIGEN VECTORS
#40PFCSP-BASED IMMUNOGENS AND RELATED COMPOSITION AND METHODS
#41COMPOSITIONS AND METHODS FOR INDUCING HUMORAL AND CELLULAR IMMUNITIES AGAINST TUMORS AND CANCER
#42METHODS OF PRODUCING BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, COMPOSITIONS THEREOF, AND METHODS OF USE THEREOF
#43A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN
#44MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#45Multivalent Vaccine Compositions
#46PREVENTING/TREATING PSEUDOMONAS AERUGINOSA INFECTION
#47PEPTIDE CONJUGATE VACCINE COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#48Neisseria Meningitidis Vaccine
#49A Conjugate
#50Anti-Alpha-Synuclein Therapeutic Vaccines
#51NANOSTRUCTURE-BASED VECTOR SYSTEM FOR BACTERIAL AND VIRAL ANTIGENS
#52TETANUS VACCINE PLATFORM FOR EMBEDDING COVID-19 VACCINE
#53IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF
#54Immunogenic Fusion Peptides Including FC Fragment and a Non Toxic B Subunit of AB5 Toxin
#55DEVELOPMENT OF SYNTHETIC PSEUDAMINIC ACID-BASED ANTIBACTERIAL VACCINES AGAINST ACINETOBACTER BAUMANNII
#56ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF
#57ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF
#58METHOD OF SAFE ADMINISTRATION OF TAU PHOSPHOPEPTIDE CONJUGATE
#59RECOMBINANT HEGF-CRM197 TUMOR THERAPEUTIC VACCINE FORMULATION
#60IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
#61IMMUNOGENIC PRODUCT COMPRISING IL-4 AND/OR IL-13 FOR TREATING DISORDERS ASSOCIATED WITH ABERRANT IL-4 AND/OR IL 13 EXPRESSION OR ACTIVITY
#62IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#63Vaccines targeting Neisseria gonorrhoeae
#64GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE VACCINE AND METHODS OF USE
#65MHC CLASS I EPITOPE DELIVERING POLYPEPTIDES
#66Multivalent Pneumococcal Polysaccharide-Protein Conjugate Composition
#67COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#68COMPOSITIONS AND METHODS FOR PREVENTING TUMORS AND CANCER
#69COMPOUNDS AND ADJUVANT FORMULATIONS USEFUL IN PNEUMOCOCCAL VACCINES
#70COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#71SYNTHETIC GLYCOCONJUGATE VACCINE PROTOTYPE AGAINST STREPTOCOCCUS SUIS
#72Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof
#73VACCINE COMPOSITIONS DEPLETING HEMATOPOIETIC GROWTH FACTORS FOR THE TREATMENT OF INFLAMMATORY DISEASES
#74HAEMOPHILUS INFLUENZAE SACCHARIDE-CARRIER CONJUGATE COMPOSITIONS AND USES THEREOF
#75Multivalent Pneumococcal Glycoconjugate Vaccines Containing Emerging Serotype 24F
#76DE-IMMUNIZED SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES FOR APPLICATIONS IN MAMMALS
#77CONJUGATED VACCINE CARRIER PROTEINS
#78METHODS FOR IMPROVING THE ADSORPTION OF POLYSACCHARIDE-PROTEIN CONJUGATES AND MULTIVALENT VACCINE FORMULATION OBTAINED THEREOF
#79METHODS OF USING SPLICING MODULATORS
#80Multi-epitope vaccine for the treatment of Alzheimer's disease
#81POLYPEPTIDE-ANTIGEN CONJUGATES WITH NON-NATURAL AMINO ACIDS
#82METHODS FOR MAKING POLYSACCHARIDE-PROTEIN CONJUGATES
#83COMPOSITIONS AND METHODS TARGETING FILAMENTOUS BACTERIOPHAGE
#84PURIFIED CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS PNEUMONIAE
#85BIOCONJUGATES OF E. COLI O-ANTIGEN POLYSACCHARIDES, METHODS OF PRODUCTION THEREOF, AND METHODS OF USE THEREOF
#86IMMUNOGENIC COMPOSITIONS AND USES THEREOF
#87BIOCONJUGATES MADE FROM RECOMBINANT N-GLYCOSYLATED PROTEINS FROM PROCARYOTIC CELLS
#88GLYCOSYLATED COMP PILIN VARIANTS, METHODS OF MAKING AND USES THEREOF
#89OPTIMIZED EPICUTANEOUS VACCINATION
#90METHODS FOR PRODUCING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CARRIER PROTEIN CONJUGATES
#91Phosphorylated Polypeptide Antigen Vaccine, Preparation Method Therefor and Application Thereof
#92Vaccines for the Treatment and Prevention of Zoonotic Infections
#93IMMUNOGENIC COMPOSITIONS FOR USE IN PNEUMOCOCCAL VACCINES
#94VACCINE
#95VACCINE FOR THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS
#96NEOGLYCOCONJUGATES AS VACCINES AND THERAPEUTIC TOOLS
#97Minimal Sequons Sufficient for O-Linking Glycosylation
#98ORAL COMPOSITIONS AND USE OF SAME IN VACCINATION
#99PATHOGEN MOIETIES AND USES THEREOF
#100Enhancing immunogenicity of polysaccharide-protein conjugates
#101VACCINE FOR THERAPEUTIC OR PROPHYLACTIC TREATMENT OF MYASTHENIA GRAVIS
#102METHODS FOR PRODUCTION OF CAPSULAR POLYSACCHARIDE PROTEIN CONJUGATES FROM STREPTOCOCCUS PNEUMONIAE SEROTYPE 19F
#103Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#104SHIGA TOXIN A SUBUNIT EFFECTOR POLYPEPTIDES, SHIGA TOXIN EFFECTOR SCAFFOLDS, AND CELL-TARGETING MOLECULES FOR SITE-SPECIFIC CONJUGATION
#105Vaccines targeting Pseudomonas aeruginosa
#106Immunogenic Composition Comprising Multivalent Streptococcus Pneumoniae Polysaccharide-Protein Conjugates
#107Klebsiella Pneumoniae O-Antigen Glycosylated Proteins and Methods of Making and Uses Thereof
#108USE OF VACCINE COMPOSITIONS BASED ON SARS-COV-2 RECEPTOR BINDING DOMAIN IN DELIVERING PROTECTIVE IMMUNITY
#109IMMUNOGENIC GLYCOPROTEIN CONJUGATES
#110Method for removal of impurities from bacterial capsular polysaccharide based preparations
#111Alphavirus neoantigen vectors
#112NOVEL CARRIERS AND CONJUGATION METHODS
#113Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#114PROTEOGLYCAN CONJUGATE AND APPLICATION THEREOF
#115COMPOSITIONS AND METHODS FOR ENHANCING T CELL PENETRATION OF TUMORS AND CANCERS
#116IMMUNOGENIC PEPTIDE AGAINST GROUP A STREPTOCOCCUS
#117COVALENT CONJUGATES OF THE SARS-COV-2 RECEPTOR-BINDING DOMAIN AND A CARRIER PROTEIN AND VACCINE COMPOSITIONS THAT CONTAIN THEM
#118IMMUNOGENIC PRODUCT COMPRISING AN IgE FRAGMENT FOR TREATING IgE-MEDIATED INFLAMMATORY DISORDERS
#119Polysaccharide and uses thereof
#120ß-AMYLOID VACCINE FOR THE TREATMENT OF ALZHEIMER’S DISEASE
#121TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS
#122ALPHA-SYNUCLEIN VACCINE FOR THE TREATMENT OF SYNUCLEINOPATHIES
#123GLYCOCONJUGATION PROCESSES AND COMPOSITIONS
#124MULTIEPITOPE VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#125Shigella-Tetravalent (Shigella4V) Bioconjugate
#126HIV-1 ENV FUSION PEPTIDE IMMUNOGENS AND THEIR USE
#127Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#128Multi-epitope vaccine for the treatment of Alzheimer's disease
#129Genetically engineered live bacteria and methods of constructing the same
#130Multi-epitope vaccine for the treatment of Alzheimer's disease
#131NEISSERIA MENINGITIDIS VACCINE
#132TLR7/8 AGONISTS TO ENHANCE IMMUNE RESPONSES IN OPIOID USING INDIVIDUALS
#133TAU VACCINE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#134Multi-epitope vaccine for the treatment of Alzheimer's disease
#135METHOD FOR RAPID IN VITRO SYNTHESIS OF GLYCOPROTEINS VIA RECOMBINANT PRODUCTION OF N-GLYCOSYLATED PROTEINS IN PROKARYOTIC CELL LYSATES
#136VACCINE COMPOSITIONS FOR INFLUENZA VIRUSES AND METHODS OF USE
#137IMMUNOGENIC COMPOSITIONS
#138INORGANIC NANOPARTICLE-BASED VACCINE COMPOSITIONS FOR CANCER TREATMENT
#139RECOMBINANT PROTEIN FOR NEUTERING OR SPAYING ANIMAL, AND VACCINE COMPOSITION COMPRISING SAME
#140Compositions and methods for rapid in vitro synthesis of bioconjugate vaccines in vitro via production and N-glycosylation of protein carriers in detoxified prokaryotic cell lysates
#141Glycoconjugation process
#142Pneumococcal conjugate vaccine formulations
#143Tetanus vaccine platform for embedding COVID-19 vaccine
#144Methods of producing bioconjugates of O-antigen polysaccharides, compositions thereof, and methods of use thereof
#145Immunogenic compositions for use in pneumococcal vaccines
#146Multi-Epitope Vaccine for the Treatment of Alzheimer's Disease
#147ADJUVANTED CONJUGATE OPIOID VACCINE
#148RECOMBINANT PROTEIN FOR REMOVING BOAR TAINT AND VACCINE COMPOSITION COMPRISING THE SAME
#149SARS-COV-2 MUCOSAL VACCINE COMPOSITION, PREPARATION AND USE THEREOF
#150IMMUNOGENIC COMPOSITIONS AGAINST ENTERIC DISEASES AND METHODS FOR ITS PREPARATION THEREOF
#151METHODS AND COMPOSITIONS FOR VIRAL VECTORED GnRH VACCINES TO CONTROL REPRODUCTION AND BREEDING BEHAVIOR IN MAMMALS
#152IMMUNOGENIC CONJUGATE INTENDED TO INDUCE AN IMMUNE RESPONSE DIRECTED AGAINST INTERLEUKIN-6
#153Bioconjugates of O-antigen polysaccharides, methods of production thereof, and methods of use thereof
#154FENTANYL HAPTENS FOR THE PREPARATION OF A FENTANYL VACCINE
#155Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
#156Methods for producing capsular polysaccharide carrier protein conjugates
#157Methods and compositions for immune protection against extra-intestinal pathogenic
#158VACCINE CONJUGATES
#159ANTIBACTERIAL CARBOHYDRATE VACCINE
#160ESCHERICHIA COLI COMPOSITIONS AND METHODS THEREOF
#161BIOFUSION PROTEINS AS ANTI-MALARIA VACCINES
#162CELL-TARGETING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT EFFECTORS AND CD8+ T-CELL EPITOPES
#163DOSAGE AND ADMINISTRATION OF A BACTERIAL SACCHARIDE GLYCOCONJUGATE VACCINE
#164IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS AND USES THEREOF
#165STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
#166IMMUNOGENIC PEPTIDE FRAGMENTS OF METALLOPROTEASE ADAMTS-7 AND USES THEREOF IN ANTI-ATHEROSCLEROSIS AND RELATED DISEASES
#167METHOD OF DETERMINING THE IDENTITY AND/OR AMOUNT OF AN ANTI-IL-31 ANTIBODY IN A SAMPLE
#168Antibodies Against Fentanyl and Fentanyl Analogs
#169Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#170Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#171saccharide-carrier conjugate compositions and uses thereof
#172Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#173Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#174COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF PRION DISEASE
#175MHC class I epitope delivering polypeptides
#176MODIFIED VIRUS-LIKE PARTICLES OF CMV
#177STABILIZED CHIMERIC SYNTHETIC PROTEINS AND THERAPEUTIC USES THEREOF
#178Immunogenic Antigens
#179Vaccines for the Treatment and Prevention of Zoonotic Infections
#180De-immunized Shiga toxin a subunit effector polypeptides for applications in mammals
#181FUSION PROTEIN CAPABLE OF SELF-ASSEMBLING INTO PROTEIN NANOPARTICLES AND APPLICATION THEREOF
#182QUANTIFICATION OF BIOCONJUGATE GLYCOSYLATION
#183Heat-Stable Enterotoxins Mutants as Antidiarrheal Vaccine Antigens
#184AN IMMUNOGENIC SEROTYPE 35B PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE AND CONJUGATION PROCESS FOR MAKING THE SAME
#185Alphavirus antigen vectors
#186CONJUGATE PRODUCTION
#187Methods of Host Cell Modification
#188METHODS AND COMPOSITIONS RELATING TO SYNTHETIC BETA-1,6 GLUCOSAMINE OLIGOSACCHARIDES
#189compositions and methods thereof
#190Shiga toxin A subunit effector polypeptides, Shiga toxin effector scaffolds, and cell-targeting molecules for site-specific conjugation
#191compositions and methods thereof
#192SACCHARIDE-POLYPEPTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE THEREOF
#193Methods for making polysaccharide-protein conjugates
#194ALPHAVIRUS NEOANTIGEN VECTORS AND INTERFERON INHIBITORS
#195Immunogenic Antigens
#196Glycoconjugation processes and compositions
#197O-LINKED GLYCOSYLATION RECOGNITION MOTIFS
#198Methods for production of capsular polysaccharide protein conjugates from serotype 19F
#199COMPOSITIONS, METHODS AND USES FOR ELICITING AN IMMUNE RESPONSE
#200Immunotherapeutic compositions for the treatment of Alzheimer's disease
#201Multivalent pneumococcal glycoconjugate vaccines containing emerging serotype 24F
#202COMBINED IMMUNIZATION AGAINST MENINGOCOCCAL DISEASE AND HUMAN PAPILLOMAVIRUS
#203Pneumococcal dosing regimen
#204Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof
#205Immunogenic compositions and uses thereof
#206Neisseria meningitidis vaccine
#207MULTIVALENT GLYCOCONJUGATES IMMUNOGENIC COMPOSITIONS
#208Vaccine against
#209Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#210Glycoconjugation process
#211BACTERIAL POLYSACCHARIDE-CONJUGATED CARRIER PROTEINS AND USE THEREOF
#212HIV-1 Env fusion peptide nanoparticle carrier conjugates and their use
#213Purified capsular polysaccharides of
#214Combination vaccine composition comprising reduced dose inactivated poliovirus and method for preparing the same
#215Methods of using splicing modulators
#216ENHANCING IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES
#217ENHANCING IMMUNOGENICITY OF STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES
#218Glycosylated ComP pilin variants, methods of making and uses thereof
#219Antibodies Targeted to Fungal Cell Wall Polysaccharides
#220TRITERPENE SAPONIN SYNTHESIS, INTERMEDIATES AND ADJUVANT COMBINATIONS
#221Low contaminant compositions
#222ExPEC glycoconjugate vaccine formulations
#223Compositions and methods for preventing tumors and cancer
#224Heroin vaccine
#225IMMUNOGENIC COMPOSITIONS COMPRISING CONJUGATED CAPSULAR SACCHARIDE ANTIGENS, KITS COMPRISING THE SAME AND USES THEREOF
#226MHC class I epitope delivering polypeptides
#227Methods for providing a homogenous solution of lyophilized mutant diptheria toxin in dimethylsulfoxide
#228Methods for producing streptococcus pneumoniae capsular polysaccharide carrier protein conjugates from lyospheres
#229Vaccine composition and uses thereof
#230IMMUNE CHECKPOINT INHIBITOR CO-EXPRESSION VECTORS
#231Immunogenic product comprising IL-4 and/or IL-13 for treating disorders associated with aberrant IL-4 and/or IL 13 expression or activity
#232Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#233COMPOSITIONS COMPRISING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE-PROTEIN CONJUGATES AND METHODS OF USE THEREOF
#234Nanovesicle derived from genus bacteria, and use thereof
#235Bacterial polysaccharide-conjugated carrier proteins and use thereof
#236Polysaccharide and uses thereof
#237Method for rapid in vitro synthesis of glycoproteins via recombinant production of n-glycosylated proteins in prokaryotic cell lysates
#238Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#239PEPTIDE IMMUNOGENS FROM THE C-TERMINAL END OF ALPHA-SYNUCLEIN PROTEIN AND FORMULATIONS THEREOF FOR TREATMENT OF SYNUCLEINOPATHIES
#240Optimized epicutaneous vaccination
#241Composition of tumor-associated proliferative peptides and related anti-cancer immunogen for the treatment of lung cancers and other cancers
#242Methods and compositions for substance use disorder vaccine formulations and uses thereof
#243Compositions against cat allergy
#244Neoglycoconjugates as vaccines and therapeutic tools
#245NEISSERIA MENINGITIDIS COMPOSITIONS AND METHODS THEREOF
#246Bioconjugates made from recombinant N-glycosylated proteins from procaryotic cells
#247Neoglycoconjugates as vaccines and therapeutic tools
#248glycoconjugate vaccines
#249METHOD FOR IMPROVING THE EFFICACY OF A SURVIVIN VACCINE IN THE TREATMENT OF CANCER
#250Methods and compositions for immune protection against extra-intestinal pathogenic
#251BIOFUSION PROTEINS AS ANTI-MALARIA VACCINES
#252composition and methods thereof
#253capsular polysaccharides and conjugates thereof
#254Immunogenic compositions
#255compositions and methods thereof
#256Peptide based PCSK9 vaccine
#257Comprehensive vaccine design for commensal disease progression
#258Immunogenic compositions and uses thereof
#259Multivalent pneumococcal polysaccharide-protein conjugate composition
#260Methods of producing bioconjugates of o-antigen polysaccharides, compositions thereof, and methods of use thereof
#261NOVEL MENINGOCOCCAL VACCINE COMPOSITION AND PROCESS THEREOF
#262Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea
#263Vaccine
#264Antibodies targeted to fungal cell wall polysaccharides
#265Immunogenic conjugates and methods of use thereof
#266Glycoconjugation process
#267Saccharide-polypeptide conjugate compositions and methods of use thereof
#268Bioconjugates of o-antigen polysaccharides, methods of production thereof, and methods of use thereof
#269Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#270Multiepitope fusion antigens and vaccines and their use in treatment of enterotoxigenic diarrhea
#271Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#272Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
#273COMPOSITION AND METHODS OF MAKING AND USING LEPTOSPIRAL LPS
#274PRECISION GLYCOCONJUGATES AS THERAPEUTIC TOOLS
#275Immunogenic glycoprotein conjugates
#276Glycoconjugation processes and compositions
#277Multivalent pneumococcal polysaccharide-protein conjugate composition
#278Multivalent pneumococcal polysaccharide-protein conjugate composition
#279HIV-1 Env fusion peptide immunogens and their use
#280Immunogenic proteins against
#281METHODS FOR PRODUCTION OF CAPSULAR POLYSACCHARIDE PROTEIN CONJUGATES FROM STREPTOCOCCUS PNEUMONIAE SEROTYPE 19F
#282Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
#283Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#284Alphavirus neoantigen vectors
#285Method for removal of impurities from bacterial capsular polysaccharide based preparations
#286Process for preparing pneumococcal polysaccharide-protein conjugates
#287Glycoconjugate vaccines, preparation method and uses thereof
#288compositions and methods thereof
#289Modified virus-like particles of CMV
#290Novel Multivalent Polysaccharide-Protein Conjugate Vaccine Composition and Formulation Thereof
#291Glycoconjugate vaccines comprising basic units of a molecular construct expressing built-in multiple epitopes for the formulation of a broad-spectrum vaccine against infections due to enteropathogenic bacteria
#292Polysaccharide and uses thereof
#293composition and methods thereof
#294METHODS AND COMPOSITIONS FOR SUBSTANCE USE DISORDER VACCINE FORMULATIONS AND USES THEREOF
#295Saccharide-polypeptide conjugate compositions and methods of use thereof
#296Lipid A mimics, methods of preparation, and uses thereof
#297ExPEC glycoconjugate vaccine formulations
#298NOVEL GLYCAN CONJUGATES AND METHODS OF USE THEREOF
#299MEDIA ELABORATED WITH NEWLY SYNTHESIZED ANTIBODIES (MENSA) AND USES THEREOF
#300Antibodies targeted to fungal cell wall polysaccharides